Abstract 739: Patient-derived xenografts allow deconvolution and prediction of chemotherapy responses
Jonathan T. Lei(Baylor College of Medicine), Michael T. Lewis(Baylor College of Medicine), Senthil Damodaran(The University of Texas MD Anderson Cancer Center), Bo Wen(University of Washington), Suhas Vasaikar(Baylor College of Medicine), Gerburg M. Wulf(Beth Israel Deaconess Medical Center), Antrix Jain(Baylor College of Medicine), Christina Sallas(Baylor College of Medicine), Meenakshi Anurag(Baylor College of Medicine), Shunqiang Li(Washington University in St. Louis), Alaina Lewis(Baylor College of Medicine), C. Kent Osborne(Texas Oncology), Chang In Moon(Baylor College of Medicine), Chen Huang(Baylor College of Medicine), Lacey E. Dobrolecki(Baylor College of Medicine), Xi Chen(University of Miami), Alexander B. Saltzman, Matthew J. Ellis(Guardant (United States)), Elisabetta Marangoni(Institut Curie), Daniel C. Kraushaar(University of Georgia), Gloria V. Echeverria(Baylor College of Medicine), Yuxing Liao(Baylor College of Medicine), Na Zhao(Baylor College of Medicine), Mothaffar F. Rimawi(Baylor College of Medicine), Susan G. Hilsenbeck(Baylor College of Medicine), Funda Meric‐Bernstam(The University of Texas MD Anderson Cancer Center), Bryan E. Welm(University of Minnesota), John D. Landua(Baylor College of Medicine), Ramakrishnan Rajaram Srinivasan(Baylor College of Medicine), Anna Malovannaya(Baylor College of Medicine), Bing Zhang(Baylor Genetics), Kai Li(Chinese Academy of Agricultural Sciences), Tao Wang, Xiaofeng Zheng(Peking University), Varduhi Petrosyan(American University of Armenia), Jin Cao(Union Hospital), Alana L. Welm(Huntsman Cancer Institute)
Cited by 0
Related Papers
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k